Title : The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

Pub. Date : 2014 Nov

PMID : 25135238






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The TP53 genotype was assessed from paraffin-embedded diagnostic tumor biopsies using a standardized gene-specific TP53 sequencing protocol (mark53 kit; mark53 Ltd, Vienna, Austria). Paraffin tumor protein p53 Homo sapiens